Table: Kyorin Pharmaceutical - 9-MTH group results

Kyorin Pharmaceutical

06/02/2024 06:00

Feb 6 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             87.27               80.71           116.20    
                 (+8.1 pct)          (+3.8 pct)       (+2.6 pct)  
  Operating          4.47                4.70             6.00    
                 (-5.0 pct)          (+60.7 pct)      (+17.1 pct) 
  Recurring          5.05                5.34             6.50    
                 (-5.3 pct)          (+51.8 pct)      (+11.5 pct) 
  Net                3.91                4.38             4.90    
                 (-10.6 pct)         (+76.3 pct)      (+3.7 pct)  
  EPS             68.23 yen           76.40 yen        85.51 yen  
  Ann Div                             52.00 yen        52.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             32.00 yen        32.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T